Drug Addiction: Clinical Trials

4 trials for Drug Addiction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 withdrawn. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 3, Withdrawn 1
Phase 21Completed 1

Follow Drug Addiction: new trials by email Literature Review of Drug Addiction trials Research Report on Drug Addiction

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Varenicline on Tobacco Addiction and on Abstinence-induced Cognitive Impairment
Varenicline - Drug Addiction
Phase 1WithdrawnNational Institute on Drug Abuse (NIDA)2011-02-132017-10-06
Family Training Program for Parents of Substance Using Adolescents
Community Reinforcement and Family Training, Al-Anon Facilitation - Substance-Related Disorders, Drug Addiction
Phase 1 / Phase 2CompletedTreatment Research Institute1262011-01-012023-03-28
Assessing Top Down and Bottom Up Attention Mechanisms in Smokers Using Nicotine Nasal Spray
Nicotrol - Drug Addiction, Nicotine Dependence
Phase 1CompletedNational Institute on Drug Abuse (NIDA)432010-01-212019-12-16
Integration of the Therapeutic Workplace in Drug Court
Therapeutic Workplace Intervention - Drug Addiction
Phase 1CompletedNational Institute on Drug Abuse (NIDA)592004-08-012017-01-10

Narrower conditions

Substance-Related Disorders (4)  ·  Smoking (2)  ·  Behavior, Addictive (1)  ·  Cocaine-Related Disorders (1)  ·  Tobacco Use Disorder (1)

Broader conditions

Chemically-Induced Disorders (4)  ·  Mental Disorders (4)  ·  Behavior (3)  ·  Compulsive Behavior (1)  ·  Impulsive Behavior (1)

Interventions

Atrial Natriuretic Factor (1)  ·  Nicotine (1)  ·  Varenicline (1)

Sponsors

National Institute on Drug Abuse (NIDA) (3)  ·  Treatment Research Institute (1)

Countries

United States (2)

Top investigators

Carol Myers, Ph.D. (1)  ·  Kimberly C Kirby, PhD (1)  ·  Stephen J Heishman, Ph.D. (1)

NIH funding

P50DA027841 (1), R21DA017885 (1)